A Study of Pegmolesatide of in Dialysis Chronic Kidney Disease (CKD) Patients With Anemia Treated With Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor (HIF-PHI)

NCT07136792 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

96

Enrollment

OTHER

Sponsor class

Conditions

Renal Anemia of Chronic Kidney Disease

Interventions

DRUG: Pegmolesatide 2mg SC
DRUG: Pegmolesatide 4mg SC
DRUG: Pegmolesatide 4mg SC
DRUG: Pegmolesatide 6mg SC

Sponsor

Guangdong Provincial People's Hospital